Factors associated with high-flow therapy failure in COVID-19-related acute hypoxemic respiratory failure: A prospective single-centre cohort study.
INTRODUCTION The optimal selection of non-invasive respiratory support for patients with COVID-19-related acute hypoxemic respiratory failure remains uncertain. High-flow therapy (HFT) is frequently used as initial support, but early identification of patients at risk of escalation is clinically relevant. We evaluated...